Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria

Clinical trial NCT04833855 · COMPLETED

Trial details

NCT number: NCT04833855
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria

Start date: 2021-04-15
Primary completion: 2022-12-20
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.